Sophiris Bio (SPHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,197 | -11,698 | -8,043 | -4,304 | -30,712 |
| Depreciation Amortization | 162 | 122 | 80 | 41 | 312 |
| Accounts receivable | 8 | -2 | 9 | N/A | 33 |
| Accounts payable and accrued liabilities | -1,728 | -1,863 | -1,870 | -1,094 | 1,171 |
| Other Working Capital | -1,104 | -1,607 | -1,976 | -1,624 | 2,124 |
| Other Operating Activity | 2,502 | 2,520 | 2,335 | 1,337 | 842 |
| Operating Cash Flow | $-14,357 | $-12,528 | $-9,465 | $-5,644 | $-26,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -9 |
| Purchase Of Investment | -10,103 | -8,052 | -5,024 | -2,598 | -28,501 |
| Sale Of Investment | 26,169 | 21,669 | 18,369 | 12,120 | 43,201 |
| Investing Cash Flow | $16,066 | $13,617 | $13,345 | $9,522 | $14,691 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,362 |
| Debt Repayment | -735 | -291 | N/A | N/A | -3,361 |
| Common Stock Issued | 785 | N/A | N/A | N/A | 1,891 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -53 |
| Financing Cash Flow | $50 | $-291 | $N/A | $N/A | $839 |
| Exchange Rate Effect | -1 | -13 | -9 | -7 | -16 |
| Beginning Cash Position | 4,123 | 4,123 | 4,123 | 4,123 | 14,839 |
| End Cash Position | 5,881 | 4,908 | 7,994 | 7,994 | 4,123 |
| Net Cash Flow | $1,758 | $785 | $3,871 | $3,871 | $-10,716 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,357 | -12,528 | -9,465 | -5,644 | -26,230 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -9 |
| Free Cash Flow | -14,357 | -12,528 | -9,465 | -5,644 | -26,239 |